In conclusion, our study reports a novelty in SSc: anti-CXCL4 antibody reactivity is frequently generated and accompanied by CXCL4-induced T-cell proliferation, which indicates that CXCL4 is acting as a novel autoantigen in SSc. The gene discussed is PF4; the disease is systemic sclerosis.